Original Research
Published on 25 Sep 2018
Different Response of Ptch Mutant and Ptch Wildtype Rhabdomyosarcoma Toward SMO and PI3K Inhibitors
in Pediatric Oncology
Frontiers in Oncology
doi 10.3389/fonc.2018.00396
- 6,221 views
- 11 citations
